Prolonged neutropenia in patients with lymphoma treated with antiretroviral therapy: Raltegravir too? A single-case report

Pediatr Blood Cancer. 2023 Apr;70(4):e30086. doi: 10.1002/pbc.30086. Epub 2022 Nov 3.

Authors

Francesco Fabozzi¹, Giuseppe Palumbo², Michela Di Pastena¹, Paola Zangari¹, Stefania Bernardi¹

Affiliations

¹ Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
² Department of Hematology/Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

PMID: 36326138
DOI: 10.1002/pbc.30086

No abstract available

Publication types

Case Reports
Editorial

MeSH terms

Anti-HIV Agents* / adverse effects
Antiretroviral Therapy, Highly Active / adverse effects
HIV Infections* / drug therapy
Humans
Lymphoma* / drug therapy
Neutropenia* / chemically induced
Pyrrolidinones / adverse effects
Raltegravir Potassium / therapeutic use
Viral Load

Substances

Raltegravir Potassium
Pyrrolidinones
Anti-HIV Agents